AFRICAN AMERICAN/NATIVE AMERICAN HEALTH

African American Application
NICaS Opportunity

Several NICaS clients who are long term users, with multiple clinic locations, have been using NICaS consistently and have increased their management of Hypertension from 53% to over 90%. Recent studies have validated the effectiveness of the NICaS.

 

 NICaS is looking to pursue physician clients with large African-American practices to develop a study specifically directed toward increasing the hypertension control within their African-American practice.

Native American Health Services

Cardiovascular disease is the leading cause of death among American Indians. The prevalence of hypertension combined with the prevalence of diabetes (American Indians have a greater chance of having diabetes than any other US racial group) creates a mix of conditions that require effective targeted medication management.

NICaS Opportunity

NICaS can provide a critical component to Indian Health Services (IHS) in the management of American Indians who struggle with determining the right combination of medications. NICaS can provide a win-win program for those physicians wishing to validate and document the success of recommended hypertension and / or diabetic medications.

 

YOU CAN’T PROVE THE EFFECTIVENESS OF MEDICATION

PROTOCOLS IF YOU CAN’T MEASURE THEM…

Please contact Tom Jordan at tjordanrcr@yahoo.com for more details. 

African-American adults are up to two times more likely to develop high blood pressure by age 55 compared to whites, with many of these racial differences developing before age 30 according to a recent study published in the Journal of the American Heart Association.

More recently there exist a higher rate of African-American deaths from Covid-19 with several discussion relating this to higher underlying conditions within the African-American population.

Additionally, Preeclampsia has a much higher occurrence in the African-American female community.

 

In managing African-American patients with Hypertension, it is important to
 

#1. Assess the overall cardiovascular risk and blood pressure goal

#2. Define the amount of blood pressure reduction required

#3. Select the drug according to the patients’ clinical profile

#4. Choose the dose according to the response curve for ethnic populations

#5. Consider the socioeconomic background of the patient

CARDIONAV  |  IPS INNOVATIVE PULMONARY SOLUTIONS

© 2020 Phoenix Healthcare Network.

Created with Wix.com